Multi-Site Gram-Negative Bacilli Surveillance Initiative (MuGSI)
Some types of bacteria are becoming resistant to all or nearly all antibiotics. This means that patients with infections from these bacteria might have few or no treatment options. Two types of these resistant bacteria are carbapenem-resistant Enterobacteriaceae (“CRE”) and multidrug-resistant (MDR) Acinetobacter. Infections due to CRE and MDR Acinetobacter occur among patients in healthcare settings, and have high death rates. Data from this tracking project will help scientists understand illness caused by these bacteria, and help shape prevention strategies to contain and prevent the spread of resistant organisms.
Specifically, the EIP MuGSI surveillance project will:
- Determine the extent of CRE and MDR Acinetobacter disease in the United States
- Identify people most at risk for illness from these organisms
- Measure trends of disease over time
In addition, the project provides infrastructure that allows future research to be done on these organisms and other Gram-negative bacteria.
Technical information about this project can be found at: Technical Information — Multi-Site Gram-Negative Bacilli Surveillance Initiative (MuGSI)